Neurocrine Biosciences (NBIX) - Stock & Dividends

Neurocrine Biosciences, Inc. is a pharmaceutical company based in the United States that specializes in developing innovative treatments for a range of neurological, neuroendocrine, and neuropsychiatric disorders globally.

Some of the notable products by Neurocrine Biosciences, Inc. include INGREZZA for tardive dyskinesia and chorea related to Huntington's disease, ALKINDI for adrenal insufficiency, Efmody capsules for classic congenital adrenal hyperplasia, Orilissa tablets for endometriosis, and Oriahnn capsules for uterine fibroids. The company also has an array of product candidates in various stages of clinical development to address different medical conditions.

In addition to its product portfolio, Neurocrine Biosciences, Inc. has formed strategic collaborations and licensing agreements with several reputable organizations like Heptares Therapeutics Limited, Takeda Pharmaceutical Company Limited, and AbbVie Inc. These partnerships contribute to the company's endeavors to introduce more effective treatment options for patients.

Established in 1992, Neurocrine Biosciences, Inc. is headquartered in San Diego, California. To learn more about the company and its initiatives, you can visit their website at https://www.neurocrine.com.